Sort   by:  
 Page size 
UnknownSafety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials.
Not available
S-EPMC9847543 | biostudies-literature
UnknownOteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial.
Not available
S-EPMC10869335 | biostudies-literature
UnknownPreclinical PK investigation of a novel IDO1/TDO dual inhibitor-SHR9146 in mouse plasma and tissues by LC-MS/MS.
Not available
S-EPMC10410440 | biostudies-literature
UnknownPreventive and Therapeutic Effects of a Novel JAK Inhibitor SHR0302 in Acute Graft-Versus-Host Disease.
Not available
S-EPMC8287347 | biostudies-literature
UnknownA Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial.
Not available
S-EPMC11129572 | biostudies-literature
UnknownImpact of Pre-PCI Activated Clotting Time on Outcomes of Bivalirudin Versus Heparin During Primary PCI.
Not available
S-EPMC12485531 | biostudies-literature
UnknownBMI differences on anticoagulation with bivalirudin vs. heparin during primary PCI: a BRIGHT-4 subanalysis.
Not available
S-EPMC12482084 | biostudies-literature
UnknownAnalysis of inter-hospital transfer on clinical outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A secondary analysis of the BRIGHT-4 trial.
Not available
S-EPMC12313069 | biostudies-literature
UnknownSafety, tolerability, pharmacokinetics and pharmacodynamics of a single intravenous dose of SHR-1707 in healthy adult subjects: two randomized, double-blind, single-ascending-dose, phase 1 studies.
Not available
S-EPMC11465679 | biostudies-literature
UnknownNeoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial.
Not available
S-EPMC12214574 | biostudies-literature
Sort   by:  
 Page size